Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

References for PMC Articles for PubMed (Select 20061547)

1.

Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart.

Chao W.

Am J Physiol Heart Circ Physiol. 2009 Jan;296(1):H1-12. doi: 10.1152/ajpheart.00995.2008. Epub 2008 Nov 14. Review.

2.

Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice.

Feng Y, Zhao H, Xu X, Buys ES, Raher MJ, Bopassa JC, Thibault H, Scherrer-Crosbie M, Schmidt U, Chao W.

Am J Physiol Heart Circ Physiol. 2008 Sep;295(3):H1311-H1318. doi: 10.1152/ajpheart.00119.2008. Epub 2008 Jul 25.

3.

Preconditioning with a TLR2 specific ligand increases resistance to cerebral ischemia/reperfusion injury.

Hua F, Ma J, Ha T, Kelley J, Williams DL, Kao RL, Kalbfleisch JH, Browder IW, Li C.

J Neuroimmunol. 2008 Aug 13;199(1-2):75-82. doi: 10.1016/j.jneuroim.2008.05.009. Epub 2008 Jun 27.

4.

The scaffold MyD88 acts to couple protein kinase Cepsilon to Toll-like receptors.

Faisal A, Saurin A, Gregory B, Foxwell B, Parker PJ.

J Biol Chem. 2008 Jul 4;283(27):18591-600. doi: 10.1074/jbc.M710330200. Epub 2008 May 5.

5.

Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice.

Riad A, Jäger S, Sobirey M, Escher F, Yaulema-Riss A, Westermann D, Karatas A, Heimesaat MM, Bereswill S, Dragun D, Pauschinger M, Schultheiss HP, Tschöpe C.

J Immunol. 2008 May 15;180(10):6954-61.

6.

Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism.

Ha T, Hua F, Liu X, Ma J, McMullen JR, Shioi T, Izumo S, Kelley J, Gao X, Browder W, Williams DL, Kao RL, Li C.

Cardiovasc Res. 2008 Jun 1;78(3):546-53. doi: 10.1093/cvr/cvn037. Epub 2008 Feb 11.

7.

Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction.

Timmers L, Sluijter JP, van Keulen JK, Hoefer IE, Nederhoff MG, Goumans MJ, Doevendans PA, van Echteld CJ, Joles JA, Quax PH, Piek JJ, Pasterkamp G, de Kleijn DP.

Circ Res. 2008 Feb 1;102(2):257-64. Epub 2007 Nov 15.

8.

Toll-like receptor 4 deficiency: smaller infarcts, but no gain in function.

Kim SC, Ghanem A, Stapel H, Tiemann K, Knuefermann P, Hoeft A, Meyer R, Grohé C, Knowlton AA, Baumgarten G.

BMC Physiol. 2007 Jun 25;7:5.

9.

Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction.

Favre J, Musette P, Douin-Echinard V, Laude K, Henry JP, Arnal JF, Thuillez C, Richard V.

Arterioscler Thromb Vasc Biol. 2007 May;27(5):1064-71. Epub 2007 Mar 1.

10.

Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury.

Sakata Y, Dong JW, Vallejo JG, Huang CH, Baker JS, Tracey KJ, Tacheuchi O, Akira S, Mann DL.

Am J Physiol Heart Circ Physiol. 2007 Jan;292(1):H503-9. Epub 2006 Sep 15.

11.

Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury.

Shimamoto A, Chong AJ, Yada M, Shomura S, Takayama H, Fleisig AJ, Agnew ML, Hampton CR, Rothnie CL, Spring DJ, Pohlman TH, Shimpo H, Verrier ED.

Circulation. 2006 Jul 4;114(1 Suppl):I270-4.

12.

Cutting edge: high-mobility group box 1 preconditioning protects against liver ischemia-reperfusion injury.

Izuishi K, Tsung A, Jeyabalan G, Critchlow ND, Li J, Tracey KJ, Demarco RA, Lotze MT, Fink MP, Geller DA, Billiar TR.

J Immunol. 2006 Jun 15;176(12):7154-8.

13.

Effect of rottlerin, a PKC-delta inhibitor, on TLR-4-dependent activation of murine microglia.

Kim DC, Kim SH, Jeong MW, Baek NI, Kim KT.

Biochem Biophys Res Commun. 2005 Nov 11;337(1):110-5.

PMID:
16182255
14.

Alarmins: chemotactic activators of immune responses.

Oppenheim JJ, Yang D.

Curr Opin Immunol. 2005 Aug;17(4):359-65. Review.

PMID:
15955682
15.

Involvement of PKCalpha/beta in TLR4 and TLR2 dependent activation of NF-kappaB.

Asehnoune K, Strassheim D, Mitra S, Yeol Kim J, Abraham E.

Cell Signal. 2005 Mar;17(3):385-94.

PMID:
15567069
16.

Immune cell Toll-like receptor 4 is required for cardiac myocyte impairment during endotoxemia.

Tavener SA, Long EM, Robbins SM, McRae KM, Van Remmen H, Kubes P.

Circ Res. 2004 Oct 1;95(7):700-7. Epub 2004 Sep 9.

17.

Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart.

Chong AJ, Shimamoto A, Hampton CR, Takayama H, Spring DJ, Rothnie CL, Yada M, Pohlman TH, Verrier ED.

J Thorac Cardiovasc Surg. 2004 Aug;128(2):170-9.

PMID:
15282452
18.

Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice.

Oyama J, Blais C Jr, Liu X, Pu M, Kobzik L, Kelly RA, Bourcier T.

Circulation. 2004 Feb 17;109(6):784-9.

19.

Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction.

Shishido T, Nozaki N, Yamaguchi S, Shibata Y, Nitobe J, Miyamoto T, Takahashi H, Arimoto T, Maeda K, Yamakawa M, Takeuchi O, Akira S, Takeishi Y, Kubota I.

Circulation. 2003 Dec 9;108(23):2905-10. Epub 2003 Dec 1.

20.

IL-1 receptor-associated kinase 1 regulates susceptibility to organ-specific autoimmunity.

Deng C, Radu C, Diab A, Tsen MF, Hussain R, Cowdery JS, Racke MK, Thomas JA.

J Immunol. 2003 Mar 15;170(6):2833-42.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk